Adaptin Bio (APTN) Debt Ratio (2022 - 2026)
Adaptin Bio's (APTN) quarterly Debt Ratio came in at 0.17 in Q2 2026, down 51.52% quarter-over-quarter from 0.34 in Q1 2026.
Analysis
Adaptin Bio (APTN) Debt Ratio (2022 - 2026) Analysis & Trends
Adaptin Bio has disclosed Debt Ratio across 4 years of filings, most recently posting 0.17 for Q2 2026.
- In Q2 2026, Debt Ratio changed N/A year-over-year to 0.17; the TTM figure through Jun 2026 stood at 0.17 (changed N/A YoY), while the FY2024 annual figure was 7.49, down 98.25% from the prior year.
- Debt Ratio came in at 0.17 for Q2 2026 at Adaptin Bio, down from 0.34 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 524.11 in Q3 2024 to a low of 0.17 in Q2 2026.
- Average Debt Ratio over 4 years is 216.04, with a median of 110.19 recorded in 2023.
- Year-over-year, Debt Ratio jumped 3929.68% in 2023 and plunged 98.25% in 2024.
- Over 4 years, Debt Ratio stood at 10.61 in 2022, then jumped by 3929.68% to 427.47 in 2023, then sank by 98.25% to 7.49 in 2024, then sank by 97.79% to 0.17 in 2026.
- Per Business Quant data, the three most recent Debt Ratio figures were 0.17 in Q2 2026, 0.34 in Q1 2026, and 7.49 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 0.22 |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 0.09 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 0.05 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 0.08 |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 0.55 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 0.27 |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | - |
| 10 | Adaptin Bio | 56.76 Mn | 56.09 Mn | - | 0.17 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.17 |
| Mar 31, 2026 | 0.34 |
| Dec 31, 2024 | 7.49 |
| Sep 30, 2024 | 524.11 |
| Jun 30, 2024 | 436.56 |
| Mar 31, 2024 | 427.47 |
| Dec 31, 2023 | 427.47 |
| Sep 30, 2023 | 110.19 |
| Dec 31, 2022 | 10.61 |